---
title: "ZJJH: Han Jianxun resigned as vice president, and Huang Bo was appointed as vice president"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280974914.md"
description: "36Kr learned that ZJJH announced that the company's board of directors recently received a written resignation letter from Vice General Manager Han Jianxun. Han Jianxun applied to resign from the position of Vice General Manager due to work adjustments and will no longer hold any position in the company after resigning. The resignation letter takes effect upon delivery to the board of directors. The 24th meeting of the ninth board of directors approved the appointment of Huang Bo as the company's Vice General Manager, with a term starting from the date of the board's approval until the end of the ninth board's term"
datetime: "2026-03-30T07:46:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280974914.md)
  - [en](https://longbridge.com/en/news/280974914.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280974914.md)
---

# ZJJH: Han Jianxun resigned as vice president, and Huang Bo was appointed as vice president

36Kr learned that ZJJH announced that the company's board of directors recently received a written resignation letter from Vice General Manager Han Jianxun. Han Jianxun applied to resign from the position of Vice General Manager due to work adjustments and will no longer hold any position in the company after resigning. The resignation letter takes effect upon delivery to the board of directors. The company's board of directors approved at the 24th meeting of the ninth session to appoint Huang Bo as the Vice General Manager of the company, with a term from the date of board approval until the end of the ninth board's term

### Related Stocks

- [600160.CN](https://longbridge.com/en/quote/600160.CN.md)

## Related News & Research

- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [Ohmium partners with RenewCO2 to advance CO2-to-chemicals technology](https://longbridge.com/en/news/287035805.md)
- [First healthy volunteers receive TRIV-573 doses in Triveni Bio’s Phase I trial](https://longbridge.com/en/news/286888745.md)
- [18:55 ETSino Biological lanza el kit de síntesis de proteínas sin células XPressMAX™](https://longbridge.com/en/news/286974640.md)
- [Defence Therapeutics Enhances In-House ADC Development Platform with Expanded Analytical and Cellular Testing Capabilities | DTCFF Stock News](https://longbridge.com/en/news/286870222.md)